Kearney Terrence C 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 3, 2022
Insider Transaction Report
Form 4
Kearney Terrence C
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-01+2,231→ 2,231 totalExercise: $276.17From: 2022-05-01Exp: 2032-04-30→ Common Stock (2,231 underlying) - Award
Common Stock
2022-05-01+725→ 6,536 total
Footnotes (1)
- [F1]Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.